Cargando…

Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review

Biofilms form a complex layer with defined structures, that attach on biotic or abiotic surfaces, are tough to eradicate and tend to cause some resistance against most antibiotics. Several studies confirmed that biofilm-producing bacteria exhibit higher resistance compared to the planktonic form of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahoo, Alaka, Swain, Shasank Sekhar, Behera, Ayusman, Sahoo, Gunanidhi, Mahapatra, Pravati Kumari, Panda, Sujogya Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265172/
https://www.ncbi.nlm.nih.gov/pubmed/34248873
http://dx.doi.org/10.3389/fmicb.2021.661195
_version_ 1783719716411408384
author Sahoo, Alaka
Swain, Shasank Sekhar
Behera, Ayusman
Sahoo, Gunanidhi
Mahapatra, Pravati Kumari
Panda, Sujogya Kumar
author_facet Sahoo, Alaka
Swain, Shasank Sekhar
Behera, Ayusman
Sahoo, Gunanidhi
Mahapatra, Pravati Kumari
Panda, Sujogya Kumar
author_sort Sahoo, Alaka
collection PubMed
description Biofilms form a complex layer with defined structures, that attach on biotic or abiotic surfaces, are tough to eradicate and tend to cause some resistance against most antibiotics. Several studies confirmed that biofilm-producing bacteria exhibit higher resistance compared to the planktonic form of the same species. Antibiotic resistance factors are well understood in planktonic bacteria which is not so in case of biofilm producing forms. This may be due to the lack of available drugs with known resistance mechanisms for biofilms. Existing antibiotics cannot eradicate most biofilms, especially of ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species). Insects produce complex and diverse set of chemicals for survival and defense. Antimicrobial peptides (AMPs), produced by most insects, generally have a broad spectrum of activity and the potential to bypass the resistance mechanisms of classical antibiotics. Besides, AMPs may well act synergistically with classical antibiotics for a double-pronged attack on infections. Thus, AMPs could be promising alternatives to overcome medically important biofilms, decrease the possibility of acquired resistance and treatment of multidrug-resistant pathogens including ESKAPE. The present review focuses on insect-derived AMPs with special reference to anti-biofilm-based strategies. It covers the AMP composition, pathways and mechanisms of action, the formation of biofilms, impact of biofilms on human diseases, current strategies as well as therapeutic options to combat biofilm with antimicrobial peptides from insects. In addition, the review also illustrates the importance of bioinformatics tools and molecular docking studies to boost the importance of select bioactive peptides those can be developed as drugs, as well as suggestions for further basic and clinical research.
format Online
Article
Text
id pubmed-8265172
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82651722021-07-09 Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review Sahoo, Alaka Swain, Shasank Sekhar Behera, Ayusman Sahoo, Gunanidhi Mahapatra, Pravati Kumari Panda, Sujogya Kumar Front Microbiol Microbiology Biofilms form a complex layer with defined structures, that attach on biotic or abiotic surfaces, are tough to eradicate and tend to cause some resistance against most antibiotics. Several studies confirmed that biofilm-producing bacteria exhibit higher resistance compared to the planktonic form of the same species. Antibiotic resistance factors are well understood in planktonic bacteria which is not so in case of biofilm producing forms. This may be due to the lack of available drugs with known resistance mechanisms for biofilms. Existing antibiotics cannot eradicate most biofilms, especially of ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species). Insects produce complex and diverse set of chemicals for survival and defense. Antimicrobial peptides (AMPs), produced by most insects, generally have a broad spectrum of activity and the potential to bypass the resistance mechanisms of classical antibiotics. Besides, AMPs may well act synergistically with classical antibiotics for a double-pronged attack on infections. Thus, AMPs could be promising alternatives to overcome medically important biofilms, decrease the possibility of acquired resistance and treatment of multidrug-resistant pathogens including ESKAPE. The present review focuses on insect-derived AMPs with special reference to anti-biofilm-based strategies. It covers the AMP composition, pathways and mechanisms of action, the formation of biofilms, impact of biofilms on human diseases, current strategies as well as therapeutic options to combat biofilm with antimicrobial peptides from insects. In addition, the review also illustrates the importance of bioinformatics tools and molecular docking studies to boost the importance of select bioactive peptides those can be developed as drugs, as well as suggestions for further basic and clinical research. Frontiers Media S.A. 2021-06-10 /pmc/articles/PMC8265172/ /pubmed/34248873 http://dx.doi.org/10.3389/fmicb.2021.661195 Text en Copyright © 2021 Sahoo, Swain, Behera, Sahoo, Mahapatra and Panda. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Sahoo, Alaka
Swain, Shasank Sekhar
Behera, Ayusman
Sahoo, Gunanidhi
Mahapatra, Pravati Kumari
Panda, Sujogya Kumar
Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review
title Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review
title_full Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review
title_fullStr Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review
title_full_unstemmed Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review
title_short Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review
title_sort antimicrobial peptides derived from insects offer a novel therapeutic option to combat biofilm: a review
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265172/
https://www.ncbi.nlm.nih.gov/pubmed/34248873
http://dx.doi.org/10.3389/fmicb.2021.661195
work_keys_str_mv AT sahooalaka antimicrobialpeptidesderivedfrominsectsofferanoveltherapeuticoptiontocombatbiofilmareview
AT swainshasanksekhar antimicrobialpeptidesderivedfrominsectsofferanoveltherapeuticoptiontocombatbiofilmareview
AT beheraayusman antimicrobialpeptidesderivedfrominsectsofferanoveltherapeuticoptiontocombatbiofilmareview
AT sahoogunanidhi antimicrobialpeptidesderivedfrominsectsofferanoveltherapeuticoptiontocombatbiofilmareview
AT mahapatrapravatikumari antimicrobialpeptidesderivedfrominsectsofferanoveltherapeuticoptiontocombatbiofilmareview
AT pandasujogyakumar antimicrobialpeptidesderivedfrominsectsofferanoveltherapeuticoptiontocombatbiofilmareview